Therini Bio, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2016-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.therinibio.com
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Double-Blind, Randomized, Placebo-Controlled, Phase 1b Study to Assess the Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of THN391 in Early Alzheimer’s Disease Subjects
- First Posted Date
- 2025-04-14
- Last Posted Date
- 2025-05-21
- Lead Sponsor
- Therini Bio Inc.
- Target Recruit Count
- 12
- Registration Number
- 2024-519899-72-00
- Locations
- 🇳🇱
CTC Netherlands B.V., Groningen, Netherlands
🇳🇱Amsterdam UMC Stichting, Amsterdam, Netherlands
News
No news found